Wellington Management Group LLP Buys 300,920 Shares of Ventas, Inc. $VTR

Wellington Management Group LLP lifted its stake in Ventas, Inc. (NYSE:VTR) by 83.7% in the 2nd quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The firm owned 660,310 shares of the real estate investment trust’s stock after purchasing an additional 300,920 shares during the period. Wellington Management Group LLP owned 0.13% of Ventas worth $58,636,000 as of its most recent SEC filing.

Several other hedge funds and other institutional investors also recently modified their holdings of the stock. BlackRock Inc. purchased a new stake in Ventas in the second quarter worth about $4,953,439,000. Capital World Investors purchased a new position in shares of Ventas in the 4th quarter valued at approximately $594,116,000. Norges Bank bought a new stake in shares of Ventas during the fourth quarter valued at approximately $474,571,000. Legal & General Group Plc bought a new stake in shares of Ventas during the second quarter valued at approximately $501,850,000. Finally, Deutsche Bank AG purchased a new stake in Ventas in the second quarter worth $451,822,000. Hedge funds and other institutional investors own 94.18% of the company’s stock.

Ventas Stock Performance

Shares of VTR stock opened at $92.14 on Friday. The company has a market capitalization of $47.26 billion, a price-to-earnings ratio of 170.63, a price-to-earnings-growth ratio of 3.59 and a beta of 0.70. The company has a debt-to-equity ratio of 0.86, a quick ratio of 0.44 and a current ratio of 0.44. Ventas, Inc. has a one year low of $66.38 and a one year high of $101.60. The company’s 50-day moving average is $92.92 and its 200 day moving average is $87.80.

Ventas (NYSE:VTR) last issued its earnings results on Wednesday, July 29th. The real estate investment trust reported $0.97 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.96 by $0.01. The business had revenue of $1.73 billion during the quarter, compared to analysts’ expectations of $1.68 billion. Ventas had a net margin of 4.08% and a return on equity of 1.99%. The business’s revenue for the quarter was up 21.7% compared to the same quarter last year. During the same period in the previous year, the company earned $0.87 earnings per share. Sell-side analysts expect that Ventas, Inc. will post 3.89 EPS for the current fiscal year.

Analyst Upgrades and Downgrades

A number of brokerages have recently commented on VTR. Royal Bank Of Canada boosted their target price on shares of Ventas from $98.00 to $99.00 and gave the company an “outperform” rating in a report on Friday, August 14th. Mizuho boosted their price objective on shares of Ventas from $98.00 to $104.00 and gave the stock an “outperform” rating in a research note on Wednesday, July 22nd. Cantor Fitzgerald raised their target price on shares of Ventas from $97.00 to $102.00 and gave the company an “overweight” rating in a research note on Friday, July 31st. Scotiabank boosted their price target on Ventas from $93.00 to $95.00 and gave the stock a “sector perform” rating in a research report on Wednesday. Finally, KeyCorp upped their price target on Ventas from $90.00 to $95.00 and gave the stock an “overweight” rating in a research note on Thursday, May 7th. Fourteen equities research analysts have rated the stock with a Buy rating and three have assigned a Hold rating to the company’s stock. According to MarketBeat, the company currently has a consensus rating of “Moderate Buy” and an average price target of $99.00.

Ventas Profile

Ventas, Inc (NYSE: VTR) is a real estate investment trust (REIT) that specializes in healthcare-related real estate. The company acquires, owns and manages a diversified portfolio of properties serving the healthcare continuum, including senior housing communities, skilled nursing facilities, medical office buildings, life science and research centers, and other properties leased to healthcare providers and operators. Ventas generates revenue through long-term leases, property management and selective development activities focused on meeting the real estate needs of the healthcare sector.

Ventas’ business model combines property ownership with active asset management and capital markets activity.